Vaccines to combat smoking

Rick A Bevins, Jamie L. Wilkinson, Sam D. Sanderson

Research output: Contribution to journalReview article

13 Citations (Scopus)

Abstract

Background: Current US FDA-approved biological therapies for treating smoking target central nervous system processes. Although these therapies have had some success, relapse within a year is still high. Clearly additional strategies are needed to aid individuals in maintaining abstinence. Objective/methods: We briefly discuss promising research using vaccines to combat smoking and then identify some potentially important directions for future research. Results/conclusions: Immunization with a nicotine vaccine generates drug-specific antibodies that sequester some of the nicotine in the peripheral circulation preventing it from entering the brain, thus decreasing its addictive effects. Albeit promising, much more research is necessary to identify more efficacious vaccine designs and formulations, as well as optimal immunization regimens. A further understanding of the factors contributing to the substantial individual differences in immunogenicity to these vaccines and how to best use vaccines in combination with other treatment strategies will increase the success of intervention efforts.

Original languageEnglish (US)
Pages (from-to)379-383
Number of pages5
JournalExpert Opinion on Biological Therapy
Volume8
Issue number4
DOIs
StatePublished - Apr 1 2008

Fingerprint

Vaccines
Smoking
Nicotine
Immunization
Combined Vaccines
Biological Therapy
Research
Individuality
Central Nervous System
Neurology
Recurrence
Antibodies
Brain
Therapeutics
Pharmaceutical Preparations
Vaccine Immunogenicity
Direction compound

Keywords

  • Cigarette
  • Cotinine
  • Drug-specific antibody
  • Immune system
  • Immunotherapy
  • Nicotine addiction
  • Tobacco

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Vaccines to combat smoking. / Bevins, Rick A; Wilkinson, Jamie L.; Sanderson, Sam D.

In: Expert Opinion on Biological Therapy, Vol. 8, No. 4, 01.04.2008, p. 379-383.

Research output: Contribution to journalReview article

Bevins, Rick A ; Wilkinson, Jamie L. ; Sanderson, Sam D. / Vaccines to combat smoking. In: Expert Opinion on Biological Therapy. 2008 ; Vol. 8, No. 4. pp. 379-383.
@article{0d3e8bc6c4d44327bc81150c8e8e98ec,
title = "Vaccines to combat smoking",
abstract = "Background: Current US FDA-approved biological therapies for treating smoking target central nervous system processes. Although these therapies have had some success, relapse within a year is still high. Clearly additional strategies are needed to aid individuals in maintaining abstinence. Objective/methods: We briefly discuss promising research using vaccines to combat smoking and then identify some potentially important directions for future research. Results/conclusions: Immunization with a nicotine vaccine generates drug-specific antibodies that sequester some of the nicotine in the peripheral circulation preventing it from entering the brain, thus decreasing its addictive effects. Albeit promising, much more research is necessary to identify more efficacious vaccine designs and formulations, as well as optimal immunization regimens. A further understanding of the factors contributing to the substantial individual differences in immunogenicity to these vaccines and how to best use vaccines in combination with other treatment strategies will increase the success of intervention efforts.",
keywords = "Cigarette, Cotinine, Drug-specific antibody, Immune system, Immunotherapy, Nicotine addiction, Tobacco",
author = "Bevins, {Rick A} and Wilkinson, {Jamie L.} and Sanderson, {Sam D.}",
year = "2008",
month = "4",
day = "1",
doi = "10.1517/14712598.8.4.379",
language = "English (US)",
volume = "8",
pages = "379--383",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Vaccines to combat smoking

AU - Bevins, Rick A

AU - Wilkinson, Jamie L.

AU - Sanderson, Sam D.

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Background: Current US FDA-approved biological therapies for treating smoking target central nervous system processes. Although these therapies have had some success, relapse within a year is still high. Clearly additional strategies are needed to aid individuals in maintaining abstinence. Objective/methods: We briefly discuss promising research using vaccines to combat smoking and then identify some potentially important directions for future research. Results/conclusions: Immunization with a nicotine vaccine generates drug-specific antibodies that sequester some of the nicotine in the peripheral circulation preventing it from entering the brain, thus decreasing its addictive effects. Albeit promising, much more research is necessary to identify more efficacious vaccine designs and formulations, as well as optimal immunization regimens. A further understanding of the factors contributing to the substantial individual differences in immunogenicity to these vaccines and how to best use vaccines in combination with other treatment strategies will increase the success of intervention efforts.

AB - Background: Current US FDA-approved biological therapies for treating smoking target central nervous system processes. Although these therapies have had some success, relapse within a year is still high. Clearly additional strategies are needed to aid individuals in maintaining abstinence. Objective/methods: We briefly discuss promising research using vaccines to combat smoking and then identify some potentially important directions for future research. Results/conclusions: Immunization with a nicotine vaccine generates drug-specific antibodies that sequester some of the nicotine in the peripheral circulation preventing it from entering the brain, thus decreasing its addictive effects. Albeit promising, much more research is necessary to identify more efficacious vaccine designs and formulations, as well as optimal immunization regimens. A further understanding of the factors contributing to the substantial individual differences in immunogenicity to these vaccines and how to best use vaccines in combination with other treatment strategies will increase the success of intervention efforts.

KW - Cigarette

KW - Cotinine

KW - Drug-specific antibody

KW - Immune system

KW - Immunotherapy

KW - Nicotine addiction

KW - Tobacco

UR - http://www.scopus.com/inward/record.url?scp=42149174454&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42149174454&partnerID=8YFLogxK

U2 - 10.1517/14712598.8.4.379

DO - 10.1517/14712598.8.4.379

M3 - Review article

VL - 8

SP - 379

EP - 383

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 4

ER -